Peter F. Lang
Director of Finance/CFO bij OPTHEA LIMITED
Actieve functies van Peter F. Lang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OPTHEA LIMITED | Director of Finance/CFO | 27-10-2023 | - |
Loopbaan van Peter F. Lang
Eerdere bekende functies van Peter F. Lang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | 18-03-2022 | 21-11-2022 |
Ridge Advisory LLC | Corporate Officer/Principal | - | - |
Opleiding van Peter F. Lang
The University of Chicago Booth School of Business | Masters Business Admin |
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Australië | 2 |
Operationeel
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
OPTHEA LIMITED | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Ridge Advisory LLC |
- Beurs
- Insiders
- Peter F. Lang
- Ervaring